Soru

Zorluk: OrtaNormal Pregnancy and Prenatal Care

Match each standard prenatal screening test or intervention with the gestational age window during which it is universally indicated for an average-risk, uncomplicated pregnancy.

  • Initial prenatal visit (typically < 10 weeks gestation)Urine culture for asymptomatic bacteriuria
  • 15 to 22 weeks gestationMaternal serum alpha-fetoprotein (MSAFP) quantification
  • 24 to 28 weeks gestation50-g, 1-hour oral glucose challenge test
  • 35 to 37 weeks gestationRectovaginal swab for Group B Streptococcus (GBS) colonization

Cevap

The initial visit matches with the urine culture for asymptomatic bacteriuria. The 15 to 22-week window matches with MSAFP quantification. The 24 to 28-week window matches with the 50-g glucose challenge test. The 35 to 37-week window matches with the rectovaginal swab for GBS.
Routine prenatal care follows a strict, evidence-based timeline. Baseline labs (including a urine culture for asymptomatic bacteriuria, CBC, HIV, RPR, and blood typing) are drawn at the initial visit. Second-trimester screening (15-22 weeks) focuses on fetal anatomic and genetic markers, notably MSAFP for neural tube defects. The 24-28 week window targets gestational diabetes screening because the secretion of human placental lactogen (hPL), which induces insulin resistance, reaches peak clinical relevance. Finally, 35-37 weeks is the optimal time for GBS screening, as results are considered valid for 5 weeks, perfectly aligning with the anticipated onset of term labor.

Adım Adım Çözüm

1
Determine the universal screening indicated at the first prenatal visit.
Urine culture is matched to the initial visit.
Early detection of asymptomatic bacteriuria is critical to prevent progression to pyelonephritis, which is a significant risk due to pregnancy-induced urinary stasis.
2
Identify the primary screening test performed in the early second trimester (15-22 weeks).
MSAFP quantification is matched to the 15-22 week window.
This is the standard window for neural tube defect screening, often performed as part of the quadruple marker screen.
3
Identify the universal screening test indicated at the end of the second trimester (24-28 weeks).
The 50-g, 1-hour glucose challenge test is matched to the 24-28 week window.
Maternal insulin resistance driven by placental hormones becomes clinically significant at this stage, making it the optimal time to screen for gestational diabetes.
4
Determine the final routine screening test performed in the late third trimester (35-37 weeks).
The rectovaginal swab for GBS is matched to the 35-37 week window.
GBS colonization can come and go, so testing must occur close to term to accurately guide intrapartum antibiotic prophylaxis.

Anahtar Kavram

Chronology of Routine Prenatal Screening
Bu soruyu puanla